FI921785A - Farmaceutisk foerening - Google Patents

Farmaceutisk foerening

Info

Publication number
FI921785A
FI921785A FI921785A FI921785A FI921785A FI 921785 A FI921785 A FI 921785A FI 921785 A FI921785 A FI 921785A FI 921785 A FI921785 A FI 921785A FI 921785 A FI921785 A FI 921785A
Authority
FI
Finland
Prior art keywords
pharmaceutical formation
pharmaceutical
formation
Prior art date
Application number
FI921785A
Other languages
English (en)
Finnish (fi)
Other versions
FI921785A0 (fi
Inventor
Gary Alan Hite
Edward David Mihelich
David Wells Snyder
Tulio Suarez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI921785A0 publication Critical patent/FI921785A0/fi
Publication of FI921785A publication Critical patent/FI921785A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI921785A 1991-04-23 1992-04-22 Farmaceutisk foerening FI921785A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/690,131 US5130485A (en) 1991-04-23 1991-04-23 N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents

Publications (2)

Publication Number Publication Date
FI921785A0 FI921785A0 (fi) 1992-04-22
FI921785A true FI921785A (fi) 1992-10-24

Family

ID=24771221

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921785A FI921785A (fi) 1991-04-23 1992-04-22 Farmaceutisk foerening

Country Status (19)

Country Link
US (1) US5130485A (zh)
EP (1) EP0510947A1 (zh)
JP (1) JPH05148218A (zh)
KR (1) KR920019739A (zh)
CN (1) CN1066060A (zh)
AU (1) AU647911B2 (zh)
BR (1) BR9201451A (zh)
CA (1) CA2066509A1 (zh)
CS (1) CS119592A3 (zh)
FI (1) FI921785A (zh)
HU (1) HU209794B (zh)
IE (1) IE921280A1 (zh)
IL (1) IL101624A0 (zh)
MX (1) MX9201809A (zh)
NO (1) NO921529L (zh)
NZ (1) NZ242427A (zh)
TW (1) TW215081B (zh)
YU (1) YU42592A (zh)
ZA (1) ZA922872B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283361A (en) * 1991-04-23 1994-02-01 Eli Lilly And Company N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND CARDIOVASCULAR AGENT AND METHODS OF USE
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
NO165341C (no) * 1985-03-16 1991-01-30 Wellcome Found Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrearylderivater.
GB8619593D0 (en) * 1986-08-12 1986-09-24 Roussel Lab Ltd Chemical compounds
US4897422A (en) * 1987-02-10 1990-01-30 Abbott Laboratories Lipoxygenase inhibiting compounds
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
CA1336099C (en) * 1987-04-24 1995-06-27 James B. Summers, Jr. Urea based lipoxygenase compounds
EP0384594B1 (en) * 1989-02-03 1993-10-27 The Wellcome Foundation Limited Anti-inflammatory aryl derivatives
WO1990012008A1 (en) * 1989-03-30 1990-10-18 Abbott Laboratories Urea based lipoxygenase inhibiting compounds

Also Published As

Publication number Publication date
US5130485A (en) 1992-07-14
AU1501692A (en) 1992-10-29
JPH05148218A (ja) 1993-06-15
CA2066509A1 (en) 1992-10-24
AU647911B2 (en) 1994-03-31
HUT61978A (en) 1993-03-29
YU42592A (sh) 1995-01-31
IE921280A1 (en) 1992-11-04
HU9201342D0 (en) 1992-07-28
BR9201451A (pt) 1992-12-01
FI921785A0 (fi) 1992-04-22
MX9201809A (es) 1994-05-31
NO921529L (no) 1992-10-26
TW215081B (zh) 1993-10-21
IL101624A0 (en) 1992-12-30
HU209794B (en) 1994-11-28
KR920019739A (ko) 1992-11-19
CS119592A3 (en) 1992-12-16
CN1066060A (zh) 1992-11-11
EP0510947A1 (en) 1992-10-28
NZ242427A (en) 1993-11-25
NO921529D0 (no) 1992-04-21
ZA922872B (en) 1993-10-21

Similar Documents

Publication Publication Date Title
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
DK0616523T3 (da) Lægemidler
FI923581A (fi) Farmaceutisk kombinationsformation
NO920067D0 (no) Foradditiv for droevtyggere
NO942923L (no) Medikamenter
NO923859D0 (no) Medikament
FI930882A0 (fi) Farmaceutiska foereningar
NO930543D0 (no) Doseringsform
FI910116A (fi) sigma-delta-modulator foer d/a-omvandlare
MX9200622A (es) Composicion farmaceutica
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A (fi) Farmaceutiska foereningar
FI921786A (fi) Farmaceutisk foerening
FI921785A (fi) Farmaceutisk foerening
DE69211197D1 (de) 1-Hydroxyvitamin D-Derivate
FI925218A0 (fi) Distansbaoge foer isolerfoerglasningar
BR9206845A (pt) Composto famacêutico
TH13625EX (th) เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท
SE9101348D0 (sv) Pharmaceutical composition
SE9103213D0 (sv) Farmaceutisk komposition
FI971316A (fi) Farmaseuttinen yhdiste

Legal Events

Date Code Title Description
FD Application lapsed